EML
Delivering Strategic 360-Degree Healthcare Communication

Pharmaceutical companies must seize every opportunity to promote their products and therapies to accelerate growth. At the same time, compliance with stringent regulations needs to be maintained. Transformative technologies can help pharma companies navigate complex regulations and find success with their marketing and communication goals.

EML, a leading 360-degree healthcare marketing and communications agency, blends excellence and innovation to offer transformative advertising solutions through Veeva and other technologies. It helps pharmaceuticals improve engagement and communication with their stakeholders, healthcare professionals, and patients.

An agency built over two decades, EML nurtures a team of over 100 bilingual and multidisciplinary experts. They produce specialized marketing content from a Latin American perspective with multinational projection, catering to diverse markets.

“We create disruptive communication strategies for local and international pharmaceutical companies with a scientific, creative, and technological vision,” says Luis Fernando Garzón, MD & CEO of EML.

Part of its strategy development entails keeping pace with the intricate and ever-evolving processes and dynamics of the pharmaceutical sector. This allows pharma companies to navigate regulatory risks and ensure no-barrier communication with any stakeholder, including healthcare professionals, pharmacists, pharma audiences, patients, and the general public.

EML employs a health-centric approach in offering six major communication strategies. These include designing advertising campaigns, creating specialized content, innovating with interactive technologies, audiovisual productions, experiential marketing, and digital marketing. An expert team of creatives, web developers, graphic designers, community managers, digital marketing specialists, and artificial intelligence experts actively collaborate to drive client success through these communication channels.

Technology plays a pivotal role in EML’s ability to make a substantial impact in the healthcare communications field. Tools like Veeva CRM Approved Email enable pharma sales reps to send tailored, approved content to healthcare providers while remaining compliant. Veeva provides invaluable insights into customer reach and engagement, enabling EML to gauge the effectiveness of its communication strategies. Experiential marketing, based on event attendance, helps it accurately assess the impact of its campaigns.

Committed to innovation, EML incorporates artificial intelligence into its processes to connect with the sector’s evolving needs through digital transformation in an omni-channel environment. It is guided by a corporate sustainability policy to ensure excellence in all its activities and the highest ethical and transparency standards.

EML’s IT and commercial teams undergo constant training and preparation to support clients and be reliable strategic allies for them. Its ability to seamlessly implement digital platforms has benefitted healthcare personnel and the pharma industry as a whole.

Managing only the creative and design aspects of digital platforms is insufficient. Agencies also need to funnel resources into developing scientific content. To obtain the IT experts needed to maintain platforms, organizations are compelled to approach multiple vendors for each platform.

We create disruptive communication strategies for local and international pharmaceutical companies with a scientific, creative, and technological vision

In response, EML’s team draws from in-depth research, analysis, planning and conceptualization to translate a client’s needs into a comprehensive marketing strategy that combines design, creativity, and scientific and technological expertise. Its solutions have the resources to provide clients with the expertise they need, delivered through a single source.

Its resourcefulness and effectiveness have earned the trust of prominent pharmaceutical companies, including AstraZeneca, Astellas, and AbbVie. In 2022 alone, EML fostered successful interactions and achieved remarkable results with over 60 pharmaceutical companies and more than 200 brands.

In the ever-changing landscape of healthcare communications, EML is propelling clients forward with its holistic scientific, creative, and technological vision. It continues to revolutionize the way pharmaceutical companies connect and engage with their healthcare stakeholders and the public, and foster commercial success in an increasingly digital era.